Legal Marijuana Sales Spiked Dramatically in 2020

January 15, 2021 (Investorideas.com Newswire) Sales of legal marijuana products rose by more than $7 billion in 2020, according to an analysis of state revenue data compiled by Leafly.com.

Commenting on the totals, NORML's Deputy Director Paul Armentano said: "The dramatic rise in retail marijuana sales is not only a reflection of increased consumer demand, but also the result of many consumers shifting from the illicit market to the above-ground legal marketplace. As these state-legal markets continue to mature and become more accessible, consumers are going to continue to gravitate toward it and away from the underground marketplace."

In all, customers purchased an estimated $17.9 billion in cannabis products from legal retailers in 2020 - up from $10.7 billion in 2019. Leafly's analysis includes sales from both medical-use and adult-use retailers.

The spike in sales was in large part due to customers purchasing greater quantities of cannabis per retail transaction than ever before. This shift began in March, at the outset of the COVID-19 pandemic, and held steadily throughout the remainder of the year.

Throughout the COVID-19 pandemic, regulators in several states designed marijuana retailers as 'essential businesses,' which permitted them to stay open under relaxed or, in some cases, new emergency rules intended to facilitate expanded customer access. As a result, several states reported an unprecedented volume of retail sales in the spring and summer.

According to Leafly's analysis, the largest marijuana sales markets in 2020 were: California, Colorado, Washington, and Florida. Nine states more than doubled their 2019 sales totals.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Buy a cannabis guest post on Investorideas.com